首页> 外文期刊>Neuropharmacology >Effects of mu opioid receptors in paraventricular nucleus on ejaculation through mediating sympathetic nerve system activity
【24h】

Effects of mu opioid receptors in paraventricular nucleus on ejaculation through mediating sympathetic nerve system activity

机译:亩阿片受体在射出射出射髓髓核中的影响通过冥想交感神经系统活动

获取原文
获取原文并翻译 | 示例
           

摘要

To investigate the roles of mu opioid receptors (MORs) in paraventricular nucleus of the hypothalamus (PVN) on ejaculation and its underlying mechanism in the rats, we performed copulation behavioral testing and acute experiments. During the acute experiments, mean arterial pressure (MAP), heart rate (HR), bulbospongiosus muscle-electromyogram (BSM-EMG) and pressure of vas deferens (P-VD) were all recorded. The expression levels and distributions of opioid receptors were also assessed in PVN of male rats. Moreover, adeno-associated virus type 1 (AAV1) was microinjected into PVN to demonstrate whether there are direct projections from PVN to lumbar spinothalamic (LSt) cells. We found that microinjection of MOR agonist, D-A1a2-NM9-Phe4-Gly(ol) 5enkephalin (DAGO), into the PVN prolonged the intromission latency and inhibited ejaculation (P = 0.0241, P = 0.0473, respectively), while the opposed results appeared in CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2, MOR antagonist) group (P = 0.0021, P = 0.0286, respectively). Moreover, DAGO caused a significant decrease in MAP and HR (P = 0.0065, P = 0.0030, respectively), and P-VD decreased significantly after DAGO microinjection in PVN (P = 0.0383). CTAP not only blocked the effect of DAGO but also significantly increased MAP, HR and P-VD (P = 0.0003, P = 0.0010, P = 0.0074, respectively). Meanwhile, a significant increase was observed in BSM-EMG activity after microinjecting of CTAP (P = 0.0022), accompanied by visible BSM contraction. Additionally, anterograde monosynaptic transneuronal tracer AAV1 labeling revealed that neurons in PVN projected directly to LSt cells in L3-4 spinal cord. These results indicate that MORs in PVN centrally mediate ejaculation by regulating the sympathetic outflow, which may be treated as a therapeutic target for ejaculation disorders in the future.
机译:为了研究Mu阿片受体(Mors)在丘脑(PVN)对大鼠射精和其底层机制的静脉内核的作用,我们进行了交配行为测试和急性实验。在急性实验期间,均记录急性实验期间,平均动脉压(MAP),心率(HR),Bulbosponyus肌电图(BSM-EMG)和VAS排出的压力(P-VD)。阿片类受体的表达水平和分布在雄性大鼠PVN中评估。此外,腺相关病毒型1(AAV1)被微量注射到PVN中,以证明是否存在从PVN到腰椎梭菌(LST)细胞的直接突出物。我们发现,MORIPERMES,D-A1A2-NM9-PHE4- GLY(OL)5苯甲酸(DAGO),进入PVN延长了对瘤潜伏期和抑制射精(P = 0.0241,P = 0.0473),而反对结果出现在CTAP(D-PHE-CYS-TYR-D-TRP-TRP-THR-THR-THR-NH2,MOR拮抗剂)组(P = 0.0021,P = 0.0286)中。此外,Dago导致MAP和HR的显着降低(P = 0.0065,P = 0.0030分别),PVN中的DAGO显微注射后P-VD显着降低(P = 0.0383)。 CTAP不仅阻塞了DAGO的效果,还显着增加了地图,HR和P-VD(P = 0.0003,P = 0.0010,P = 0.0074)。同时,在微内注射CTAP(P = 0.0022)后,在伴有可见BSM收缩后,在BSM-EMG活性中观察到显着增加。另外,蒽曲面蒙扰动胎儿突厥Aav1标记显示PVN中的神经元直接突出到LST细胞中L3-4脊髓。这些结果表明,PVN中的Mors通过调节交感神经流出来集中介导射精,这可能被视为未来射精障碍的治疗靶标。

著录项

  • 来源
    《Neuropharmacology》 |2019年第2019期|共8页
  • 作者单位

    Nanjing Med Univ Affiliated Hosp 1 Dept Urol 300 Guangzhou Rd Nanjing Jiangsu Peoples R China;

    Nanjing Med Univ Affiliated Hosp 1 Dept Urol 300 Guangzhou Rd Nanjing Jiangsu Peoples R China;

    Nanjing Med Univ Affiliated Hosp 1 Dept Urol 300 Guangzhou Rd Nanjing Jiangsu Peoples R China;

    Nanjing Med Univ Affiliated Hosp 1 Dept Urol 300 Guangzhou Rd Nanjing Jiangsu Peoples R China;

    Nanjing Med Univ Dept Physiol Key Lab Cardiovasc Dis &

    Mol Intervent Nanjing Jiangsu Peoples R;

    Nanjing Med Univ Affiliated Hosp 1 Dept Urol 300 Guangzhou Rd Nanjing Jiangsu Peoples R China;

    Nanjing Med Univ Affiliated Hosp 1 Dept Urol 300 Guangzhou Rd Nanjing Jiangsu Peoples R China;

    Nanjing Med Univ Affiliated Hosp 1 Dept Urol 300 Guangzhou Rd Nanjing Jiangsu Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药理学;
  • 关键词

    Ejaculation; Sexual behavior; Paraventricular nucleus; Mu opioid receptor; Sympathetic nerve system activity;

    机译:射精;性行为;椎间盘核;亩阿片受体;交感神经系统活动;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号